Pay in 4 interest-free payments of $6.20 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Garetosmab, activin A inhibitor antibody for muscle-preservation combination regimens in obesity Recent Highlights: In June 2026, the company announced it would present new clinical data from the Phase 2 COURAGE trial that examines the effects of trevogrumab (anti-GDF8) on lean mass in people with obesity treated with semaglutide
10.3760/j.issn.1673-4777.2023.12.027 31 WangZ
Research Characteristics: Tripeptidecopper complex studied for its role in cellular signaling and biological regulation Investigated for activity in collagen synthesis pathways and tissue remodeling Examined in laboratory research for effects on oxidative stress and inflammatory balance THIS PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only
Step 2: Consult with a licensed provider
US$ 23.44
US$ 28.12
US$ 21.44
US$ 29.24
US$ 20.87
US$ 22.72
